La OMS recomienda el uso de anlogos GLP-1 para combatir la epidemia mundial de obesidad Salud El organismo tambin pide a las farmacuticas que los hagan ms accesibles aumentando la produccin, escalonando los precios y que autoricen a otras empresas a fabricarlos y venderlos para bajar los precios La Organizacin Mundial de la Salud (OMS) ha emitido hoy una recomendacin en favor del uso de tres medicamentos anlogos del GLP-1, concebidos originalmente para tratar la diabetes tipo 2, en pacientes con obesidad, una enfermedad que afecta a 1.000 millones de personas, cifra que podra duplicarse en apenas cinco aos
Similar mean reductions in A1C versus placebo were observed for patients using saxagliptin 5 mg add-on to insulin alone and saxagliptin 5 mg add-on to insulin in combination with metformin HCl immediate-release (-0.4% and -0.4%, respectively)
They can help you determine when it is safe to take your next dose from a fresh pen
Canadian Journal of Physiology and Pharmacology
While prescription weight loss medications are generally well-tolerated, some people may experience mild side effects as their bodies adjust to treatment
Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase